Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
24.16 USD | +5.07% | +3.29% | -21.17% |
02:56pm | Intellia Therapeutics' Q1 Net Loss Narrows, Collaboration Revenue Rises | MT |
04-15 | Intellia Therapeutics, Inc. Appoints Michael P. Dube as Principal Accounting Officer | CI |
- Stock Market
- Equities
- NTLA Stock
- News Intellia Therapeutics, Inc.
- MarketScreener Strategies